Skip to main content
Clinical Trials/NCT00923039
NCT00923039
Unknown
Not Applicable

The Early Origins of Cardiovascular Disease : the Consequence of Growth Restriction During Foetal Life and Infancy on Cardiovascular Structure and Function in Adulthood

Danone Institute International1 site in 1 country200 target enrollmentJune 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
Danone Institute International
Enrollment
200
Locations
1
Primary Endpoint
To determine how size at birth and growth during infancy and childhood affect: body composition, cardiac structure and function, vascular and endothelial function, renal function, metabolic status and transcriptional and epigenetic characteristics
Last Updated
16 years ago

Overview

Brief Summary

Small body size at birth, slow weight gain during infancy and increase in body mass index after 2 years are independent risk factors for cardiovascular disease and the metabolic syndrome. There is a large gap in our understanding of how early growth affects the cardiovascular system. Possible mechanisms include alterations in body composition, in cardiac structure, in vascular function, in renal function and epigenetic processes.

The Objective is to determine how size at birth and growth during infancy and childhood affect: body composition, cardiac structure and function, vascular and endothelial function, renal function, metabolic status and transcriptional and epigenetic characteristics.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
TBD
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Danone Institute International

Eligibility Criteria

Inclusion Criteria

  • Male and female volunteers students aged between 18-25 years old
  • Having growth records

Exclusion Criteria

  • If young women subject without contraception,or pregnant

Outcomes

Primary Outcomes

To determine how size at birth and growth during infancy and childhood affect: body composition, cardiac structure and function, vascular and endothelial function, renal function, metabolic status and transcriptional and epigenetic characteristics

Time Frame: 3 years

Study Sites (1)

Loading locations...

Similar Trials